Capstone Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Capstone Investment Advisors, LLC

  • $24.9 Billion
  • Q1 2024

A detailed history of Capstone Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 31,025 shares of BMY stock, worth $1.25 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,025
Previous 382,100 91.88%
Holding current value
$1.25 Million
Previous $19.6 Million 91.42%
% of portfolio
0.01%
Previous 0.06%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024
SELL
$47.98 - $54.4 $15.4 Million - $17.5 Million
-321,271 Reduced 91.19%
31,025 $1.68 Million
Q4 2023

Feb 12, 2024
BUY
$48.48 - $57.85 $4.71 Million - $5.62 Million
97,184 Added 38.09%
352,296 $18.1 Million
Q3 2023

Nov 13, 2023
BUY
$57.89 - $64.73 $4.71 Million - $5.27 Million
81,437 Added 46.89%
255,112 $14.8 Million
Q2 2023

Aug 10, 2023
BUY
$63.71 - $70.74 $4.7 Million - $5.22 Million
73,794 Added 73.88%
173,675 $11.1 Million
Q1 2023

May 09, 2023
BUY
$65.71 - $74.53 $6.14 Million - $6.96 Million
93,396 Added 1440.19%
99,881 $6.92 Million
Q4 2022

Feb 10, 2023
BUY
$68.48 - $81.09 $403,004 - $477,214
5,885 Added 980.83%
6,485 $466,000
Q3 2022

Nov 10, 2022
BUY
$0.13 - $76.84 $78 - $46,104
600 New
600 $43,000
Q4 2021

Feb 11, 2022
SELL
$53.63 - $62.52 $7.57 Million - $8.82 Million
-141,128 Reduced 54.28%
118,893 $7.41 Million
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $14.4 Million - $16.9 Million
244,053 Added 1528.39%
260,021 $15.4 Million
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $555,170 - $629,109
9,615 Added 151.35%
15,968 $990,000
Q2 2020

Aug 14, 2020
BUY
$54.82 - $64.09 $340,103 - $397,614
6,204 Added 4163.76%
6,353 $374,000
Q4 2019

Feb 14, 2020
SELL
$49.21 - $64.19 $413,364 - $539,196
-8,400 Reduced 98.26%
149 $10,000
Q2 2019

Aug 14, 2019
SELL
$44.62 - $49.34 $411,485 - $455,013
-9,222 Reduced 51.89%
8,549 $388,000
Q1 2019

May 15, 2019
SELL
$45.12 - $53.8 $514,503 - $613,481
-11,403 Reduced 39.09%
17,771 $848,000
Q4 2018

Feb 14, 2019
BUY
$48.76 - $63.23 $695,073 - $901,343
14,255 Added 95.55%
29,174 $1.52 Million
Q3 2018

Nov 14, 2018
BUY
$55.19 - $62.25 $266,015 - $300,045
4,820 Added 47.73%
14,919 $926,000
Q2 2018

Aug 13, 2018
BUY
$50.53 - $62.98 $386,352 - $481,545
7,646 Added 311.7%
10,099 $559,000
Q1 2018

May 15, 2018
BUY
$59.92 - $68.98 $146,983 - $169,207
2,453 New
2,453 $155,000

Others Institutions Holding BMY

# of Institutions
2,553
Shares Held
1.49B
Call Options Held
25.9M
Put Options Held
20M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email